US price cuts, Medicare expansion, and new oral GLP-1 approvals reshape the competitive outlook for weight-loss drugs.

From there, a licensed provider reviews your responses and makes a personal recommendation, which could include a GLP-1 ...

Weight loss isn't the only change Individuals who are taking a GLP-1 weight loss medicine are seeing. They also tend to spend ...

Weight regain is common after stopping GLP-1s, as appetite increases and the body tries to return you to your previous weight ...

Families using GLP-1s are spending less on food, from grocery stores to restaurants, according to a study published Dec. 18 ...

A meta-analysis of 10,362 patients with inflammatory bowel disease has found that GLP-1 receptor agonists are safe and ...

Novo Nordisk plans to quickly launch the pill form of Wegovy but is expected to soon face competition from Eli Lilly.

Both Novo Nordisk’s and competitor Eli Lilly’s injectable GLP-1 drugs, Wegovy and Zepbound, have helped transform obesity ...

At the end of the day, GLP-1s can be a powerful tool for achieving your weight loss goals, but only if they're safe and ...

Chronic pain teaches you to gamble with yourself. There’s always one more treatment, one more possible cure, one more ...

There is no exact known number of GLP-1 patients who say their say their sense of taste has changed since starting the ...

The debate over whether insurers should pay for GLP-1 drugs like Ozempic and Wegovy has revived a familiar American argument ...